MSD to invest €7m in Carlow

International healthcare giant MSD — formerly Merck Sharp and &Dohme — is to strengthen its Irish operations via an additional €7m investment in its Carlow facility.

The move brings to €227m the company’s total investment in Carlow and will create an additional 20 contract-based jobs in the areas of engineering, automation and project management.

New technological capabilities will also be added at the state-of-the-art facility, which will allow for the manufacture of the firm’s newest pipeline of vaccine and biologic products for treatment across a range of disease areas, including rheumatology, oncology and pneumonia.